Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents

Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents

US Patent 7312240 · Granted Dec 25, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prostaglandin receptor EP2 antagonists, derivatives, and uses related thereto2025
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses rela2021
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses rela2020
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses rela2018
Quinazoline derivatives, compositions, and uses related thereto2018
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses rela2018
Quinazoline compounds and their use in therapy2018
Quinazoline derivatives, compositions, and uses related thereto2018
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses rela2016
Piperazine derivatives, compositions, and uses related thereto2016
Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agen2013
Morning glory-derived anticancer agents, and novel ipomoeassin compounds2009